Abstract
The rate at which nosocomial infections have spread throughout the globe has been alarming. Therefore, the data presented here sheds light on some aspects of AgNPs as promising anti-infective therapy. However, knowledge on the safe usage of AgNPs in the field of medicine is necessary to investigate. AgNPs synthesis, optimization, characterization, and mode of action against Enterococcus faecalis have been studied in this paper. We propose a combination of cell-free supernatant (C-FS) of the intimate organisms; Fusarium solani and Comamonas aquatica as synthesis catalysts. The optimization findings were at pH 9.0 for 72 h in 1 mM AgNO3 using 1:2 v/v (C-FS : AgNO3). UV-vis absorption peak appeared at 425 nm and the crystalline nature of synthesized particles was verified by XRD. FTIR analysis confirmed the presence of protein molecules that acted as reducing and stabilizing agents. Energy-dispersive X-ray analysis exhibited an intense peak at 3 KeV, confirming the formation of AgNPs. Further, FE-SEM images prove AgNPs synthesis. TEM and AFM analysis demonstrated that fabricated AgNPs were relatively monodispersed, approximately spherical, and of size 2-7.5 nm. The growth and biofilm of nosocomial E. faecalis were significantly decreased by the action of AgNPs. Furthermore, antibiotic resistance genes, blaTEM, and blaCTX, were detected in E. faecalis; both genes were degraded enormously via 9 % AgNPs. This is the first study proposing alternative sources to form AgNPs via synergistic metabolites of F. solani and C. aquatica. The results here offer a foundation for developing an effective therapy using AgNPs against nosocomial pathogens.